Michael T. Heffernan, R. Ph
2017
In 2017, Michael T. Heffernan, R. Ph earned a total compensation of $2.8M as President and Chief Executive Officer at Collegium Pharmaceutical, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $346,800 |
|---|---|
| Option Awards | $1,091,958 |
| Salary | $546,609 |
| Stock Awards | $839,850 |
| Other | $17,559 |
| Total | $2,842,776 |
Ph received $1.1M in option awards, accounting for 38% of the total pay in 2017.
Ph also received $346.8K in non-equity incentive plan, $546.6K in salary, $839.9K in stock awards and $17.6K in other compensation.
Rankings
In 2017, Michael T. Heffernan, R. Ph's compensation ranked 3,839th out of 14,666 executives tracked by ExecPay. In other words, Ph earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,839 out of 14,666 | 74th |
Division Manufacturing | 1,340 out of 5,768 | 77th |
Major group Chemicals And Allied Products | 376 out of 2,074 | 82nd |
Industry group Drugs | 290 out of 1,730 | 83rd |
Industry Pharmaceutical Preparations | 230 out of 1,329 | 83rd |
Source: SEC filing on April 13, 2018.
Ph's colleagues
We found four more compensation records of executives who worked with Michael T. Heffernan, R. Ph at Collegium Pharmaceutical in 2017.